Dr. Josh Almond-Thynne
Co-Founder and Chief Scientific Officer
Prior to founding Sable, Josh helped deliver two pre-clinical candidates at BenevolentAI as a medicinal chemist. He pioneered the use of unstructured data in medicinal chemistry.
Josh gained his Ph.D. in organic chemistry from Imperial College London, and has held research positions at the University of Oxford, CSIRO, and Boehringer Ingelheim.
